PMID- 30257250 OWN - NLM STAT- MEDLINE DCOM- 20181023 LR - 20220408 IS - 1421-9778 (Electronic) IS - 1015-8987 (Linking) VI - 49 IP - 6 DP - 2018 TI - Schizandrin A Alleviates LPS-Induced Injury in Human Keratinocyte Cell Hacat Through a MicroRNA-127-Dependent Regulation. PG - 2229-2239 LID - 10.1159/000493826 [doi] AB - BACKGROUND/AIMS: Inflammatory skin diseases are the most common problems in dermatology. Schizandrin A (SchA) has been reported to have anti-inflammatory properties. Herein, we aimed to investigate the protective effects of SchA on lipopolysaccharide (LPS)-induced injury in keratinocyte HaCaT cells. METHODS: Inflammation injury in HaCaT cells was induced by LPS treatment. Cell viability, apoptotic cell rate, and apoptosis-related proteins were analyzed by cell counting kit-8 (CCK-8) assay, Annexin V-(fluorescein isothiocyanate (FITC)/ Propidium Iodide (PI) double staining method, and western blot, respectively. The pro-inflammatory factors were analyzed by western blot and quantified by enzyme linked immunosorbent assay (ELISA). Expression of miR-127 in SchA-treated cells was analyzed by qRT-PCR. The effects of SchA on activations of p38MAPK/ERK and JNK pathways were analyzed by western blot. RESULTS: SchA protected HaCaT cells from LPS-induced inflammation damage via promoting cell viability, suppressing apoptosis. Meanwhile, SchA inhibited IL-1beta, IL-6, and TNF-alpha expression. miR-127 expression was up-regulated in LPS-treated HaCaT cells but down-regulated after SchA treatment. Overexpression of miR-127 inhibited cell growth and induced expression of IL-1beta, IL-6 and TNF-alpha. Additionally, miR-127 overexpression impaired the protective effects of SchA, implying miR-127 might be correlated to the anti-inflammation property of SchA and also involved in inactivation of p38MAPK/ERK and JNK pathways by SchA. CONCLUSION: miR-127 is involved in the protective functions of SchA on LPS-induced inflammation injury in human keratinocyte cell HaCaT, which might inactivates of p38MAPK/ERK and JNK signaling pathways in HaCaT cells. CI - (c) 2018 The Author(s). Published by S. Karger AG, Basel. FAU - Li, Shujie AU - Li S AD - Department of Rheumatology and Immunology, Jining No. 1 People's Hospital, Jining, China. FAU - Xie, Ruijin AU - Xie R AD - Department of Gastroenterology, Jining No. 1 People's Hospital, Jining, China. FAU - Jiang, Chengrui AU - Jiang C AD - Department of Rheumatology and Immunology, Jining No. 1 People's Hospital, Jining, China. FAU - Liu, Mei AU - Liu M AD - Department of Gastroenterology, Jining No. 1 People's Hospital, Jining, China. LA - eng PT - Journal Article PT - Retracted Publication DEP - 20180926 PL - Germany TA - Cell Physiol Biochem JT - Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology JID - 9113221 RN - 0 (Antagomirs) RN - 0 (Cyclooctanes) RN - 0 (Interleukin-1beta) RN - 0 (Interleukin-6) RN - 0 (Lignans) RN - 0 (Lipopolysaccharides) RN - 0 (MIRN127 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (Polycyclic Compounds) RN - 0 (Tumor Necrosis Factor-alpha) RN - 74XQL5DO3S (schizandrin A) RN - EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) SB - IM ECI - Cell Physiol Biochem. 2021;55(4):536. PMID: 34735052 RIN - Cell Physiol Biochem. 2022 Feb 26;56(1):85. PMID: 35235275 MH - Antagomirs/metabolism MH - Apoptosis/*drug effects MH - Cell Line MH - Cell Survival/drug effects MH - Cyclooctanes/*pharmacology MH - Humans MH - Interleukin-1beta/metabolism MH - Interleukin-6/metabolism MH - JNK Mitogen-Activated Protein Kinases/metabolism MH - Keratinocytes/cytology/drug effects/metabolism MH - Lignans/*pharmacology MH - Lipopolysaccharides/toxicity MH - MAP Kinase Signaling System/drug effects MH - MicroRNAs/antagonists & inhibitors/genetics/*metabolism MH - Polycyclic Compounds/*pharmacology MH - Tumor Necrosis Factor-alpha/metabolism MH - p38 Mitogen-Activated Protein Kinases/metabolism OTO - NOTNLM OT - Inflammation OT - JNK pathway OT - P38MAPK/ERK pathway OT - Schizandrin A OT - miR-127 EDAT- 2018/09/27 06:00 MHDA- 2018/10/24 06:00 CRDT- 2018/09/27 06:00 PHST- 2017/11/29 00:00 [received] PHST- 2018/09/18 00:00 [accepted] PHST- 2018/09/27 06:00 [pubmed] PHST- 2018/10/24 06:00 [medline] PHST- 2018/09/27 06:00 [entrez] AID - 000493826 [pii] AID - 10.1159/000493826 [doi] PST - ppublish SO - Cell Physiol Biochem. 2018;49(6):2229-2239. doi: 10.1159/000493826. Epub 2018 Sep 26.